A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Illumina, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 58,897 shares of ILMN stock, worth $8.42 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
58,897
Previous 58,894 0.01%
Holding current value
$8.42 Million
Previous $6.15 Million 24.94%
% of portfolio
0.04%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$105.28 - $135.9 $315 - $407
3 Added 0.01%
58,897 $7.68 Million
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $3.74 Million - $4.94 Million
-36,981 Reduced 38.57%
58,894 $6.15 Million
Q1 2024

May 13, 2024

BUY
$127.73 - $147.2 $4.79 Million - $5.52 Million
37,486 Added 64.2%
95,875 $13.2 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $446,969 - $686,567
4,817 Added 8.99%
58,389 $8.13 Million
Q3 2023

Nov 09, 2023

SELL
$128.91 - $192.44 $77,217 - $115,271
-599 Reduced 1.11%
53,572 $7.36 Million
Q2 2023

Aug 07, 2023

BUY
$183.43 - $232.67 $1.37 Million - $1.74 Million
7,458 Added 15.97%
54,171 $10.2 Million
Q1 2023

May 11, 2023

SELL
$193.75 - $232.55 $131,362 - $157,668
-678 Reduced 1.43%
46,713 $10.9 Million
Q4 2022

Feb 08, 2023

BUY
$187.24 - $242.74 $2.18 Million - $2.83 Million
11,651 Added 32.6%
47,391 $9.58 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $1.26 Million - $1.61 Million
-7,086 Reduced 16.55%
35,740 $6.82 Million
Q2 2022

Aug 10, 2022

SELL
$181.58 - $368.0 $2.41 Million - $4.89 Million
-13,281 Reduced 23.67%
42,826 $7.9 Million
Q1 2022

May 11, 2022

SELL
$303.87 - $423.8 $903,405 - $1.26 Million
-2,973 Reduced 5.03%
56,107 $19.6 Million
Q4 2021

Feb 10, 2022

SELL
$347.28 - $421.83 $145,163 - $176,324
-418 Reduced 0.7%
59,080 $22.7 Million
Q3 2021

Nov 10, 2021

BUY
$405.61 - $524.84 $302,990 - $392,055
747 Added 1.27%
59,498 $24.1 Million
Q2 2021

Aug 10, 2021

SELL
$372.84 - $481.5 $836,280 - $1.08 Million
-2,243 Reduced 3.68%
58,751 $27.8 Million
Q1 2021

May 14, 2021

SELL
$361.28 - $504.76 $1.08 Million - $1.51 Million
-2,993 Reduced 4.68%
60,994 $23.4 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $696,333 - $882,513
2,379 Added 3.86%
63,987 $23.7 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $1.56 Million - $2.33 Million
5,808 Added 10.41%
61,608 $19 Million
Q2 2020

Aug 13, 2020

SELL
$256.46 - $373.01 $815,029 - $1.19 Million
-3,178 Reduced 5.39%
55,800 $20.7 Million
Q1 2020

May 13, 2020

SELL
$209.2 - $335.53 $4.82 Million - $7.72 Million
-23,018 Reduced 28.07%
58,978 $16.1 Million
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $7.35 Million - $8.55 Million
25,491 Added 45.11%
81,996 $27.2 Million
Q3 2019

Nov 08, 2019

SELL
$266.84 - $378.23 $1.12 Million - $1.58 Million
-4,184 Reduced 6.89%
56,505 $17.2 Million
Q2 2019

Aug 09, 2019

SELL
$300.59 - $368.15 $3 Million - $3.68 Million
-9,986 Reduced 14.13%
60,689 $22.3 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $2.59 Million - $3.06 Million
9,520 Added 15.57%
70,675 $22 Million
Q4 2018

Feb 12, 2019

BUY
$272.46 - $366.54 $443,837 - $597,093
1,629 Added 2.74%
61,155 $18.3 Million
Q3 2018

Nov 05, 2018

SELL
$279.04 - $367.06 $267,878 - $352,377
-960 Reduced 1.59%
59,526 $21.9 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $408,652 - $523,097
1,791 Added 3.05%
60,486 $16.9 Million
Q1 2018

Apr 30, 2018

SELL
$209.54 - $253.91 $3.64 Million - $4.41 Million
-17,352 Reduced 22.82%
58,695 $13.9 Million
Q4 2017

Feb 12, 2018

SELL
$202.23 - $230.03 $2.68 Million - $3.04 Million
-13,230 Reduced 14.82%
76,047 $16.6 Million
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $972,978 - $1.21 Million
5,647 Added 6.75%
89,277 $17.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
83,630
83,630 $0

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.